Compounds / GH Axis / GHRP-2

GHRP-2

GHRP-2 (Growth Hormone-Releasing Peptide 2 — Hexapeptide)
GH AxisFDA: Not approvedWADA: PROHIBITED — Category S2

Overview

Potent GH secretagogue with clinical pharmacology data. Once-daily dosing avoids receptor attenuation. Mild ACTH/cortisol elevation differentiates from Ipamorelin.

Mechanism of Action

Potent GHS-R1a agonist (hexapeptide). Stimulates dose-dependent GH release. Less selective than Ipamorelin — mild cortisol and prolactin elevation possible at higher doses. Once-daily preferred to avoid attenuation.

Molecular Profile

Molecular weight
817.9 Da
CAS number
158861-67-7

Key Research Findings

Potent GH stimulation; mild cortisol elevation possible; dose-dependent; once-daily preferred.

Published Research

J Endocrinol Invest (1997)
Arvat E et al. Preliminary data on the metabolic effects of GHRP-2 in humans
View source

Related GH Axis Compounds

IpamorelinCJC-1295 (No DAC)CJC-1295 (DAC)SermorelinTesamorelinGHRP-6
Clinical Guidance

Research data is not a treatment plan. If you are considering GHRP-2, the questions that matter are whether it suits your history, your labs and your goals. That is a conversation with a licensed physician, not a lookup.

Speak with a physician LATOM Wellness is a physician-led telehealth practice. Consultation only. No compound is sold on this site.
Running GHRP-2? Log doses and track your cycle.

Interactive tools for this compound:

Reconstitution calculator  ·  Full deep dive  ·  Peptide fundamentals